INTERCURE
InterCure is a medical device company that has developed and patented a technology platform for respiratory-based treatment of cardiovascular and pulmonary diseases. The Company has incorporated its "Interactive Respiratory-Pacing" technology platform into several product lines, the first two of which offer a new therapeutic class of non-drug treatments for two of the most widespread and costly disease states in the healthcare industry: hypertension and heart failure. InterCure’s first marke... t-ready product, RESPeRATE, is the only FDA-cleared, medical device clinically proven to lower high blood pressure with no side effects. InterCure's heart failure product, InTone™ has successfully completed phase 2a efficacy clinical trials and is expected to be launched when it completes the regulatory approval process. With its outstanding management team, the board of directors and a world-class Scientific Advisory Board, Intercure is poised to become the market leader in patient-focused medical devices that provide non-drug, no-side-effect treatment for some of the world's most prevalent and costly chronic conditions. InterCure was founded in 1994 and is headquartered in Ra'anana, Israel.
INTERCURE
Industry:
Health Care Manufacturing Medical Device Therapeutics
Founded:
1994-01-01
Address:
Ra'anana, HaMerkaz, Israel
Country:
Israel
Website Url:
http://www.intercure.com
Total Employee:
51+
Status:
Active
Contact:
201-720-7750
Email Addresses:
[email protected]
Total Funding:
41.9 M USD
Technology used in webpage:
SPF Nginx Citrix NetScaler DOSarrest Uniregistry
Similar Organizations
Inogen
Inogen is a manufacturer and an accredited homecare provider dedicated to oxygen therapy.
Lannett Company
Lannett develops, manufactures, and distributes generic prescription pharmaceutical products in tablet.
Nimbus Therapeutics
Nimbus Discovery is now Nimbus Therapeutics to reflect our transition into a clinical stage company.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
SomaLogic
SomaLogic is a protein biomarker discovery and clinical diagnostics company, offers SOMAmer technology to improve diagnostic products.
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2018-09-04 | Canndoc | Canndoc acquired by InterCure | N/A |
Investors List
ARK Investment Management
ARK Investment Management investment in Post-IPO Equity - InterCure
Adam Neumann
Adam Neumann investment in Post-IPO Equity - InterCure
GMF Capital
GMF Capital investment in Post-IPO Equity - InterCure
Nippon Venture Capital
Nippon Venture Capital investment in Series C - InterCure
Medica Venture Partners
Medica Venture Partners investment in Series C - InterCure
Arie Ovadia
Arie Ovadia investment in Series B - InterCure
Palladin Consumer Retail Partners
Palladin Consumer Retail Partners investment in Series B - InterCure
Daniel Plotkin
Daniel Plotkin investment in Series B - InterCure
Medica Venture Partners
Medica Venture Partners investment in Series B - InterCure
True North Partners
True North Partners investment in Series B - InterCure
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2015-12-23 | Fore Biotherapeutics | InterCure investment in Venture Round - Fore Biotherapeutics | 10 M USD |
Official Site Inspections
http://www.intercure.com
- Host name: a904c694c05102f30.awsglobalaccelerator.com
- IP address: 13.248.169.48
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
